Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPM4 pseudogene 3 (TPM4P3)
- Target
- TPM4P3
- Molecular classification
- Other (pseudogene)
01
Overview
TPM4 pseudogene 3 (TPM4P3) is a nonfunctional genomic sequence derived from the TPM4 gene, which codes for a member of the tropomyosin family of actin-binding proteins involved in cytoskeletal structure and muscle contraction. Unlike TPM4, TPM4P3 is classified as a pseudogene, lacks protein-coding potential, and is not considered a therapeutic target or biomarker. References to TPM4P3 in the literature may sometimes be mistaken for the functional gene (TPM4), which plays significant roles in cancer biology, cell migration, and cytoskeletal regulation. No evidence supports any direct biological role, disease association, or druggability for TPM4P3 itself.
- Other names
- TPM4P3TPM4 pseudogene 3
Beyond the preview
Go deeper on TPM4 pseudogene 3 (TPM4P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TPM4 pseudogene 3 (TPM4P3).